Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs

Movement Disorders

Volumn 24, Issue 8, 2009, Pages 1226-1229

  Schneider, Susanne A ^a   Udani, Vrajesh ^b   Sankhla, Charulata Sawant ^b   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

Acute dystonic reaction; Antidopaminergic treatment; Dystonia; Neuroleptics; Oculogyric crisis

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOBAZAM; DIAZEPAM; DIPHENHYDRAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; HALOPERIDOL; LITHIUM; METHYLPREDNISOLONE; METOCLOPRAMIDE; PARACETAMOL; PROCYCLIDINE; STEROID; TETRABENAZINE; TRIMIPRAMINE; VALPROIC ACID;

ADULT; ARTICLE; BRAIN DAMAGE; CASE REPORT; CERVICAL DYSTONIA; CHILD; CHOREA; DIZZINESS; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; FALLING; FEMALE; HUMAN; HYPERSALIVATION; JAW SPASM; MALE; MIGRAINE; MUSCLE SPASM; OCULOGYRIC CRISIS; PRIORITY JOURNAL; RECURRENT DISEASE; RESTLESSNESS; RHEUMATIC CHOREA; SINGLE DRUG DOSE;

ADULT; CHILD; DISEASE PROGRESSION; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; DYSTONIA; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; OCULAR MOTILITY DISORDERS;

EID: 67651149809     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22532     Document Type: Article

References (19)

1. Jhee SS, Zarotsky V, Mohaupt SM, Yones CL, Sims SJ. Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol. Ann Pharmacother 2003;37:1434-1437.
2. Sethi KD. Drug-induced Movement Disorders. New York, Basel: Marcel Dekker; 2006.
3. Jain KK. Drug-induced movement disorders. In: Jain KK, editor. Drug-induced neurological disorders. Göttingen, Germany, Hogrefe&Huber; 1996. p 137-164.
4. Bhatt M, Sethi KD, Bhatia KP. Acute and tardive dystonia. In: Sethi KD, ed. Drug-Induced Movement Disorders. New York: Marcel Dekker; 2006. p 111-128.
5. Mendhekar DN. Recurrent oculogyric crisis and retrocollis after re-exposure with a low dose of olanzapine. Indian J Pharmacol 2005;37:337.
6. Sachdev P. Tardive and chronically recurrent oculogyric crises. Mov Disord 1993;8:93-97.
7. Vilensky JA, Goetz CG, Gilman S. Movement disorders associated with encephalitis lethargica: a video compilation. Mov Disord 2006;21:1-8.
8. Lee MS, Kim YD, Lyoo CH. Oculogyric crisis as an initial manifestation of Wilson's disease. Neurology 1999;52:1714-1715.
9. Kakigi R, Shibasaki H, Katafuchi Y, Iyatomi I, Kuroda Y. [The syndrome of bilateral paramedian thalamic infarction associated with an oculogyric crisis]. Rinsho Shinkeigaku 1986;26:1100-1105.
10. Shimpo T, Fuse S, Yoshizawa A. [Retrocollis and oculogyric crisis in association with bilateral putaminal hemorrhages]. Rinsho Shinkeigaku 1993;33:40-44.
11. Zorzi G, Zibordi F, Ghezzi D, Barzaghi C, Garavaglia B, Nardocci N. Clinical and aetiological spectrum of dopa-responsive syndromes. In: Nardocci N, Fernandes-Alvarez E, editors. Movement disorders in children: a clinical update with video recordings. Paris: John Libbey Eurotext; 2007. p 105-112.
12. Khanderia U. Recurrent dystonic reactions induced by thiethylperazine. Drug Intell Clin Pharm 1985;19:550-551.
13. Schwingenschuh P, Pont-Sunyer C, Surtees R, Edwards MJ, Bhatia KP. Psychogenic movement disorders in children: A report of 15 cases and a review of the literature. Mov Disord 2008;23: 1882-1888.
14. Gomeza J, Zhang L, Kostenis E, et al. Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice. Life Sci 2001;68:2457-2466.
15. Blanchet PJ, Calon F, Morissette M, et al. Relevance of the MPTP primate model in the study of dyskinesia priming mechanisms. Parkinsonism Relat Disord 2004;10:297-304.
16. van der PA, van Schaik RH, Sonneveld P. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms. Neth J Med 2006;64: 160-162.
17. Foltynie T, Cheeran B, Williams-Gray CH, et al. BDNF val66-met Influences time to onset of levodopa-induced dyskinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2009;80: 141-144.
18. Schneider SA, Bhatia K. Paroxysmal dyskinesias - An overview. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders, 5 ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p 459-467.
19. Hanna MG. Genetic neurological channelopathies. Nat Clin Pract Neurol 2006;2:252-263.